Key result
Symposium presentations highlighted that blood pressure control remains suboptimal in Europe, emphasizing the need for simplified treatment algorithms, single-pill combinations, and new technologies.
Why the study?
Does a guided treatment protocol using single-pill fixed-dose combinations improve blood pressure control compared to standard of care in hypertensive patients?
Does a guided treatment protocol using single-pill fixed-dose combinations improve blood pressure control compared to standard of care in hypertensive patients?
Despite available medications, blood pressure control in Europe remains suboptimal, emphasizing the need for simplified treatment regimens like single-pill fixed-dose combinations and the integration of new technologies to overcome physician inertia and patient non-adherence.
Suboptimal European BP control persists; leaves open whether simplified algorithms or single-pill combinations improve outcomes in practice.
Prof Williams opened the symposium by discussing the current state of blood pressure (BP) control in Europe and the key barriers to improving BP control rates. Prof Weiss presented the ‘Low BP in Vienna’ initiative that has been initiated in Austria in order to improve BP control. Prof Mourad discussed the ongoing campaign to improve BP control rates in France, and Prof Volpe presented a case study of an elderly patient with hypertension and chronic kidney disease (CKD). Prof Parati concluded the symposium by commenting on the improvements in technology with respect to BP control. The meeting objectives were to review the current achievement of BP goals in Europe since 2008; to evaluate the 70% BP goal initiatives in France and Italy; to use practical examples to assess the use of single-pill fixed-dose combinations (FDCs); and to assess the impact of technological advances on BP control.
No takes yet. Share an insight, caveat, or question.
Lynda McEvoy (2015) conducted a review in Hypertension. Blood pressure management strategies (including single-pill fixed-dose combinations and telemonitoring) was evaluated. Symposium presentations highlighted that blood pressure control remains suboptimal in Europe, emphasizing the need for simplified treatment algorithms, single-pill combinations, and new technologies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: